- Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI)
- The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance
- The study focuses to identify digital biomarkers to aid monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as AD
Click here to read full press release/ article | Ref: Biogen | Image: MyHealthyApp
The post Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline first appeared on PharmaShots.